Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), announces that the first patient has been ...

Cambridge biopharma company Microbiotica reveals that the first patient has been dosed in its Phase 1b First-in-Human trial, ...

Corvus Pharmaceuticals Inc (CRVS) progresses with promising trials and designations, despite reporting a significant net loss for the quarter.

Research shows stimulating the vagus nerve can relieve a host of health problems and create feelings of calm. Could a new ...

This report offers a comprehensive analysis of the global cervical cancer research ... approaches in inflammatory bowel disease (IBD) including ulcerative colitis, today announces that its lead ...

a biotechnology company developing a clinical pipeline of orally administered ... patients suffering from gastrointestinal diseases such as celiac disease, inflammatory bowel disease and other ...

Ventyx Biosciences, Inc. ( (VTYX) ) has released its Q3 earnings. Here is a breakdown of the information Ventyx Biosciences, Inc. presented to its investors. Ventyx Biosciences, Inc. is a ...

inflammatory bowel disease and fibrotic diseases with a host of additional indications identified for future work. Now for an ...

The School of Dental Medicine at the University of Buffalo (UB) has received a $7.3 million grant from the Office of Research ...

Turmeric is a natural herb that may affect how well other medications and supplements work. This includes cancer medications ...

Current research is focused on unravelling the complex mechanisms ... such as rheumatoid arthritis and inflammatory bowel disease, is crucial. This multifaceted approach allows for a comprehensive ...

GenEdit, Inc., a developer of genetic medicines that leverage its NanoGalaxy platform for tissue-selective delivery, today announced the appointment of J. Rodrigo Mora, M.D., Ph.D., as Chief ...